{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:42:59Z","timestamp":1786545779242,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1038\/s41395-018-0168-7","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T11:12:33Z","timestamp":1529925153000},"page":"1167-1176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial"],"prefix":"10.14309","volume":"113","author":[{"given":"Hyung Joon","family":"Yim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Jun","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Kul","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Young","family":"Yim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon Seok","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Rim","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Young","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Ik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon Ho","family":"Um","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210404","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0168-8278(05)80280-6","article-title":"A prospective study of bacterial infections in patients with cirrhosis.","volume":"18","author":"Caly","year":"1993","journal-title":"J Hepatol"},{"key":"R2-15-20210404","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00001574-200105000-00012","article-title":"Portal hypertension.","volume":"17","author":"Garcia-Tsao","year":"2001","journal-title":"Curr Opin Gastroenterol"},{"key":"R3-15-20210404","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/gast.2001.22580","article-title":"Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis.","volume":"120","author":"Garcia-Tsao","year":"2001","journal-title":"Gastroenterology"},{"key":"R4-15-20210404","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.","volume":"53","year":"2010","journal-title":"J Hepatol"},{"key":"R5-15-20210404","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0168-8278(98)80061-5","article-title":"Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial.","volume":"29","author":"Grange","year":"1998","journal-title":"J Hepatol"},{"key":"R6-15-20210404","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hep.1840120416","article-title":"Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial.","volume":"12","author":"Gines","year":"1990","journal-title":"Hepatology"},{"key":"R7-15-20210404","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis.","volume":"133","author":"Fernandez","year":"2007","journal-title":"Gastroenterology"},{"key":"R8-15-20210404","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","article-title":"Management of adult patients with ascites due to cirrhosis: an update.","volume":"49","author":"Runyon","year":"2009","journal-title":"Hepatology"},{"key":"R9-15-20210404","first-page":"1171","article-title":"Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial.","volume":"22","author":"Rolachon","year":"1995","journal-title":"Hepatology"},{"key":"R10-15-20210404","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/00365521.2016.1245776","article-title":"Comparison of clinical characteristics and outcomes of spontaneous bacterial peritonitis and culture negative neutrocytic ascites.","volume":"52","author":"Na","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"R11-15-20210404","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0016-5085(91)90219-B","article-title":"Selective intestinal decontamination prevents spontaneous bacterial peritonitis.","volume":"100","author":"Soriano","year":"1991","journal-title":"Gastroenterology"},{"key":"R12-15-20210404","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1111\/j.1572-0241.2001.04668.x","article-title":"Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis.","volume":"96","author":"Bauer","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R13-15-20210404","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/S0168-8278(97)80474-6","article-title":"Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites.","volume":"26","author":"Guarner","year":"1997","journal-title":"J Hepatol"},{"key":"R14-15-20210404","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3350\/cmh.2012.18.4.337","article-title":"The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension.","volume":"18","author":"Seo","year":"2012","journal-title":"Clin Mol Hepatol"},{"key":"R15-15-20210404","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/hep.28330","article-title":"Antibiotic prophylaxis in cirrhosis: good and bad.","volume":"63","author":"Fernandez","year":"2016","journal-title":"Hepatology"},{"key":"R16-15-20210404","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.1840200619","article-title":"Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis.","volume":"20","author":"Follo","year":"1994","journal-title":"Hepatology"},{"key":"R17-15-20210404","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","article-title":"Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013.","volume":"60","author":"Jalan","year":"2014","journal-title":"J Hepatol"},{"key":"R18-15-20210404","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1007\/BF01782702","article-title":"Spontaneous bacterial peritonitis in liver cirrhosis: treatment and prophylaxis.","volume":"22","author":"Arroyo","year":"1994","journal-title":"Infection"},{"key":"R19-15-20210404","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cgh.2008.12.018","article-title":"Role of fluoroquinolones in the primary prophylaxis of spontaneous bacterial peritonitis: meta-analysis.","volume":"7","author":"Loomba","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R20-15-20210404","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1440-1746.2005.03796.x","article-title":"Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.","volume":"20","author":"Sandhu","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"R21-15-20210404","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1128\/AAC.38.2.340","article-title":"Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis.","volume":"38","author":"Dupeyron","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"R22-15-20210404","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0168-8278(99)80225-6","article-title":"Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences.","volume":"31","author":"Aparicio","year":"1999","journal-title":"J Hepatol"},{"key":"R23-15-20210404","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2036.2005.02366.x","article-title":"Norfloxacin decreases bacterial adherence of quinolone-resistant strains of Escherichia coli isolated from patients with cirrhosis.","volume":"21","author":"Gascon","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R24-15-20210404","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/hep.510290406","article-title":"Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.","volume":"29","author":"Ortiz","year":"1999","journal-title":"Hepatology"},{"key":"R25-15-20210404","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0168-8278(98)80062-7","article-title":"Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis: results of short- and long-term administration, with daily and weekly dosages.","volume":"29","author":"Terg","year":"1998","journal-title":"J Hepatol"},{"key":"R26-15-20210404","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/liv.12152","article-title":"Increasing frequency of gram-positive cocci and gram-negative multidrug-resistant bacteria in spontaneous bacterial peritonitis.","volume":"33","author":"Alexopoulou","year":"2013","journal-title":"Liver Int"},{"key":"R27-15-20210404","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/hep.27941","article-title":"The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial.","volume":"63","author":"Piano","year":"2016","journal-title":"Hepatology"},{"key":"R28-15-20210404","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/apt.13435","article-title":"Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis.","volume":"43","author":"Bajaj","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"R29-15-20210404","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/gutjnl-2015-309421","article-title":"Comparison of the in vitro susceptibility of rifaximin versus norfloxacin against multidrug resistant bacteria in a hospital setting. A proof-of-concept study for use in advanced cirrhosis.","volume":"65","author":"Ramos","year":"2016","journal-title":"Gut"},{"key":"R30-15-20210404","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000081990","article-title":"Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential.","volume":"51","author":"Scarpignato","year":"2005","journal-title":"Chemotherapy"},{"key":"R31-15-20210404","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/MCG.0b013e3182506dbb","article-title":"The role of rifaximin in the primary prophylaxis of spontaneous bacterial peritonitis in patients with liver cirrhosis.","volume":"46","author":"Hanouneh","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"R32-15-20210404","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/MEG.0000000000000724","article-title":"Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.","volume":"28","author":"Elfert","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41395-018-0168-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41395-018-0168-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41395-018-0168-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201808000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:46:25Z","timestamp":1786542385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201808000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1038\/s41395-018-0168-7","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}